Related references
Note: Only part of the references are listed.Novel Chemosensitive Single-Nucleotide Polymorphism Markers to Targeted Regimens in Metastatic Colorectal Cancer
Jin C. Kim et al.
CLINICAL CANCER RESEARCH (2011)
Impact of Toll-like receptor 4 polymorphisms on risk of cancer
Anton G. Kutikhin
HUMAN IMMUNOLOGY (2011)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Toll-like Receptors in Regulatory T Cells of Patients With Head and Neck Cancer
Clarissa Anni Wild et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2010)
Chemosensitivity Profiles Identify Polymorphisms in the p53 Network Genes 14-3-3t and CD44 That Affect Sarcoma Incidence and Survival
Alexei Vazquez et al.
CANCER RESEARCH (2010)
In vivo depletion of T lymphocyte-specific transcription factors by RNA interference
Antoine Tesniere et al.
CELL CYCLE (2010)
Tobacco abuse relates to significantly reduced survival of patients with oropharyngeal carcinomas
Eva Hilgert et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2009)
Impact of Toll-like receptors [TLR] 2 (-196 to-174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women
Saumya Pandey et al.
GYNECOLOGIC ONCOLOGY (2009)
Toll-like receptors and cancer
Seth Rakoff-Nahoum et al.
NATURE REVIEWS CANCER (2009)
Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies
Lionel Apetoh et al.
CANCER RESEARCH (2008)
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes
D. Santini et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene
Goetz F. Lehnerdt et al.
CLINICAL CANCER RESEARCH (2008)
Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity
J. Todd Auman et al.
DRUG METABOLISM REVIEWS (2008)
The anticancer immune response: indispensable for therapeutic success?
Laurence Zitvogel et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Cancers take their Toll - the function and regulation of Toll-like receptors in cancer cells
R. Chen et al.
ONCOGENE (2008)
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
IMMUNOLOGICAL REVIEWS (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Case-control study of human papillomavirus and oropharyngeal cancer
Gypsyamber D'Souza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors
Georgina L. Hold et al.
GASTROENTEROLOGY (2007)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Lipopolysaccharide signaling in endothelial cells
SM Dauphinee et al.
LABORATORY INVESTIGATION (2006)
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
MEC Lutsiak et al.
BLOOD (2005)
High-mobility group box 1 protein (HMGB): Nuclear weapon in the immune arsenal
MT Lotze et al.
NATURE REVIEWS IMMUNOLOGY (2005)
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
F Ghiringhelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Toll-like receptor 4 (TLR4)-deficient murine macrophage cell line as an in vitro assay system to show TLR4-independent signaling of Bacteroides fragilis lipopolysaccharide
E Lorenz et al.
INFECTION AND IMMUNITY (2002)
Toll-like receptor 4 polymorphisms and atherogenesis
S Kiechl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock
E Lorenz et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
NC Arbour et al.
NATURE GENETICS (2000)
Share Paper
